Вход на сайт
COVID-19: Прививки
118560 просмотров
Перейти к просмотру всей ветки
в ответ pfeiferm1966 13.01.21 20:03
- 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest
- 91% efficacy in high-risk populations
- 100% efficacy against variants "not considered Variants of Concern/Interest"
- All COVID-19 hospitalizations/death occurred in the placebo group